|
Name |
9-Decenoic acid
|
Molecular Formula | C10H18O2 | |
IUPAC Name* |
dec-9-enoic acid
|
|
SMILES |
C=CCCCCCCCC(=O)O
|
|
InChI |
InChI=1S/C10H18O2/c1-2-3-4-5-6-7-8-9-10(11)12/h2H,1,3-9H2,(H,11,12)
|
|
InChIKey |
KHAVLLBUVKBTBG-UHFFFAOYSA-N
|
|
Synonyms |
9-Decenoic acid; dec-9-enoic acid; 14436-32-9; Caproleic acid; 9-decylenic acid; FEMA No. 3660; Delta(9)-decenoic acid; U2E27P3TGK; C10:1n-1; 9-DECENOICACID; UNII-U2E27P3TGK; EINECS 238-410-9; 9Z-DECENOIC ACID; SCHEMBL94016; 9-DECENOIC ACID [FHFI]; CH2=CH-(CH2)7-COOH; CHEBI:32381; FEMA 3660; DTXSID30162685; 9-Decenoic acid, >=95%, FG; ZINC1850646; 9-Decenoic acid, analytical standard; LMFA01030033; MFCD00036663; STL301782; AKOS006222510; FS-3942; DB-042730; CS-0217815; D1932; FT-0637081; EN300-86170; N12000; A808208; J-007945; Q27114910
|
|
CAS | 14436-32-9 | |
PubChem CID | 61743 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 170.25 | ALogp: | 3.3 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 12 | QED Weighted: | 0.444 |
Caco-2 Permeability: | -5.044 | MDCK Permeability: | 0.00002690 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.576 |
30% Bioavailability (F30%): | 0.438 |
Blood-Brain-Barrier Penetration (BBB): | 0.444 | Plasma Protein Binding (PPB): | 92.03% |
Volume Distribution (VD): | 0.25 | Fu: | 4.76% |
CYP1A2-inhibitor: | 0.056 | CYP1A2-substrate: | 0.364 |
CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.309 |
CYP2C9-inhibitor: | 0.039 | CYP2C9-substrate: | 0.971 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.335 |
CYP3A4-inhibitor: | 0.02 | CYP3A4-substrate: | 0.044 |
Clearance (CL): | 2.907 | Half-life (T1/2): | 0.808 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.075 |
Drug-inuced Liver Injury (DILI): | 0.016 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.231 | Maximum Recommended Daily Dose: | 0.025 |
Skin Sensitization: | 0.825 | Carcinogencity: | 0.153 |
Eye Corrosion: | 0.983 | Eye Irritation: | 0.99 |
Respiratory Toxicity: | 0.641 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000263 | 0.658 | D0Z5BC | 0.917 | ||||
ENC000259 | 0.636 | D0E4WR | 0.581 | ||||
ENC000088 | 0.610 | D0FD0H | 0.500 | ||||
ENC000460 | 0.605 | D0O1PH | 0.394 | ||||
ENC000075 | 0.581 | D0O1TC | 0.391 | ||||
ENC000030 | 0.579 | D0XN8C | 0.373 | ||||
ENC000270 | 0.568 | D0UE9X | 0.364 | ||||
ENC000593 | 0.568 | D0EP8X | 0.342 | ||||
ENC000625 | 0.565 | D0I4DQ | 0.325 | ||||
ENC000455 | 0.561 | D09SRR | 0.317 |